Viridian Therapeutics, Inc.\DE (VRDN) EBT Margin Growth (1y) (2014 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - | 5.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | 10.63 Mn |
| Jun 30, 2025 | -4.76 Mn |
| Mar 31, 2025 | -5.07 Mn |
| Dec 31, 2024 | 706,528.00 |
| Sep 30, 2024 | -4.02 Mn |
| Jun 30, 2024 | -2.49 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -7.35 Mn |
| Sep 30, 2023 | -6.38 Mn |
| Jun 30, 2023 | -6.49 Mn |
| Mar 31, 2023 | -5.77 Mn |
| Dec 31, 2022 | -2.98 Mn |
| Sep 30, 2022 | 432,960.00 |
| Jun 30, 2022 | -988,982.00 |
| Mar 31, 2022 | -1.06 Mn |
| Dec 31, 2021 | 15.44 Mn |
| Jun 30, 2021 | 250,312.00 |
| Mar 31, 2021 | -25,400.00 |